* Cellectar Biosciences (NASDAQ:CLRB [https://seekingalpha.com/symbol/CLRB]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open.
* The consensus EPS Estimate is -$3.70 [https://seekingalpha.com/symbol/CLRB/earnings/estimates].
* Over the last 1 year, CLRB has beaten EPS estimates [https://seekingalpha.com/symbol/CLRB/earnings/eps-surprise-summary] 0% of the time and has beaten revenue estimates 0% of the time.
* Over the last 3 months, EPS estimates have seen 3 upward revisions [https://seekingalpha.com/symbol/CLRB/earnings/revisions] and 0 downward.
MORE ON CELLECTAR BIOSCIENCES
* Cellectar Biosciences announces one-for-thirty reverse stock split [https://seekingalpha.com/news/4459704-cellectar-biosciences-announces-one-for-thirty-reverse-stock-split]
* Cellectar Biosciences enters into common stock agreements to raise $2.5 million [https://seekingalpha.com/news/4455853-cellectar-biosciences-enters-into-common-stock-agreements-to-raise-25-million]
* Seeking Alpha’s Quant Rating on Cellectar Biosciences [https://seekingalpha.com/symbol/CLRB/ratings/quant-ratings]
* Historical earnings data for Cellectar Biosciences [https://seekingalpha.com/symbol/CLRB/earnings]
* Financial information for Cellectar Biosciences [https://seekingalpha.com/symbol/CLRB/income-statement]
Cellectar Biosciences Q2 2025 Earnings Preview
Published 2 months ago
Aug 13, 2025 at 5:23 PM
Positive
Auto